A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/435 (2006.01) A61K 31/437 (2006.01) A61P 3/00 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01) A61P 9/00 (2006.01) A61P 25/28 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2413277
The invention relates to the use of inhibitors of the microsomal triglyceride transfer protein (MTP) for reducing the number of postprandial triglyceride- rich lipoprotein particles (ppTRL) or for reducing their decomposition products i.e. the cholesterol-rich "small remnant particle" (remnants). Said particles are associated with apolipoprotein B-48 (ApoB-48) and are designated as "ppTRL" in the further course of events.
L'invention concerne l'utilisation d'inhibiteurs de protéine de transfert de triglycérides microsomale (MTP) pour abaisser le taux de particules de lipoprotéine à forte teneur en triglycérides postprandiaux (ppTRL) ou pour abaisser leurs produits de décomposition, en d'autres termes les <= petites particules résiduelles >= àforte teneur en cholestérine. Lesdites particules sont associées à de l'aloliprotéine B-48 (ApoB-48) et sont qualifiées par la suite de <= ppTRL >=.
Bischoff Hilmar
Grutzmann Rudi
Muller Ulrich
Zaiss Siegfried
Aktiengesellschaft Bayer
Fetherstonhaugh & Co.
LandOfFree
Use of microsomal triglyceride transfer protein (mtp)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of microsomal triglyceride transfer protein (mtp)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of microsomal triglyceride transfer protein (mtp)... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1714179